A short review on antibody therapy for COVID-19

被引：44
|
作者：
Kumar, G. Venkat [1 ]
Jeyanthi, V [2 ]
Ramakrishnan, S. [3 ]
机构：
[1] Ponnaiyah Ramajayam Inst Sci & Technol, Dept Biotechnol, Thanjavur 613403, Tamil Nadu, India
[2] SRM Arts & Sci Coll, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India
[3] NCI, Struct Biophys Lab, Ctr Canc Res, Frederick, MD 21702 USA
来源：
NEW MICROBES AND NEW INFECTIONS | 2020年 / 35卷
关键词：
Convalescent plasma therapy; monoclonal antibody therapy; receptor binding domain; SARS-CoV-2; spike protein; CONVALESCENT PLASMA; SARS CORONAVIRUS; SPIKE; PROTEIN; BINDING;
D O I：
10.1016/j.nmni.2020.100682
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
The beginning of the novel SARS-CoV-2 human coronavirus in Wuhan, China, has triggered a worldwide respiratory disease outbreak (COVID-19). By April 07, 2020, SARS-CoV-2 has affected more than 1.36 million people worldwide and caused more than 75,900 deaths. To date, the anti-malaria drug hydroxychloroquine found to be a treatment option for SARS-CoV-2. In addition to supportive treatment, such as oxygen supply in moderate cases and extracorporeal membrane oxygenation in critically ill patients, unique medications for this condition are also under investigation. Here we reviewed the antibody therapy might be an immediate strategy for emergency prophylaxis and SARS-CoV-2 therapy. (C) 2020 The Authors. Published by Elsevier Ltd.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
    Fabrizio Cantini
    Delia Goletti
    Linda Petrone
    Saied Najafi Fard
    Laura Niccoli
    Rosario Foti
    [J]. Drugs, 2020, 80 : 1929 - 1946
  • [42] Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review
    Cantini, Fabrizio
    Goletti, Delia
    Petrone, Linda
    Fard, Saied Najafi
    Niccoli, Laura
    Foti, Rosario
    [J]. DRUGS, 2020, 80 (18) : 1929 - 1946
  • [43] Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy
    Casadevall, Arturo
    Joyner, Michael J.
    Pirofski, Liise-Anne
    Senefeld, Jonathon W.
    Shoham, Shmuel
    Sullivan, David
    Paneth, Nigel
    Focosi, Daniele
    [J]. EXPERT REVIEW OF RESPIRATORY MEDICINE, 2023, 17 (05) : 381 - 395
  • [44] COVID-19: a review
    Madabhavi, Irappa
    Sarkar, Malay
    Kadakol, Nagaveni
    [J]. MONALDI ARCHIVES FOR CHEST DISEASE, 2020, 90 (02) : 248 - 258
  • [45] COVID-19 Review
    Reichardt, Alina
    [J]. DEUTSCHES ARZTEBLATT INTERNATIONAL, 2020, 117 (29-30):
  • [46] A Systematic Review of COVID-19 Vaccine Antibody Responses in People With HIV
    Chun, Helen M.
    Milligan, Kyle
    Agyemang, Elfriede
    Ford, Nathan
    Rangaraj, Ajay
    Desai, Shalini
    Wilder-Smith, Annelies
    Vitoria, Marco
    Zulu, Isaac
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2022, 9 (11):
  • [47] Covid-19: Timing is critical for antibody tests, finds Cochrane review
    Wise, Jacqui
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 369 : m2584
  • [48] Geriatric Antibody Response to COVID-19
    Moore, J. J.
    Groves, T.
    Ashcraft, A.
    Assadzandi, S.
    Shrader, C.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2021, 69 : S9 - S9
  • [49] Monoclonal Antibody for Patients with Covid-19
    Jaworski, Juan P.
    Lundgren, Jens D.
    Lane, H. Clifford
    Neaton, James D.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1170 - 1171
  • [50] COVID-19 Antibody Tests: An Overview
    Ravi, Arjun B.
    Singh, V. P. Prabath
    Chandran, Roshni
    Venugopal, Krishnan
    Haridas, Kaushik
    Kavitha, R.
    [J]. JOURNAL OF PHARMACY AND BIOALLIED SCIENCES, 2021, 13 (05): : 48 - 51
12345